A Study to Observe How Adolescent Patients With Severe Atopic Dermatitis Despite Less Extensive Skin Lesions (Eczema Area and Severity Index Score < 16) Respond to Dupilumab Treatment

NCT06192563 · clinicaltrials.gov ↗
UNKNOWN
Status
150
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Sanofi